This section contains documents published by the various BOPA subcommittees including infomation about the 2018 BOPA Bursary Scheme Subcommittee
BOPA Social Media PolicyPlease see attached the new BOPA Social Media Policy. This is a guide for members on using social media to promote the work of BOPA and in a personal capacity.
Why we need a social media policy
The difference between a personal and professional opinion can be blurred on social media, particularly if you're discussing issues relating to BOPA. While BOPA encourages the use of social media, there are certain standards, outlined in this policy, which BOPA require everyone to observe. Publication and commentary on social media carries similar obligations to any other kind of publication or commentary in the public domain.
Who is it intended for?
This policy is intended for all members when posting professionally and/or mentioning BOPA in posts, even when not posting on behalf of BOPA. It applies to all BOPA members when posting from their own accounts if they reference or mentioning BOPA in their posts or include affiliation to BOPA in their social media profile. Before engaging in BOPA social media activity, members should read this policy.
BOPA expects that any suppliers, contractors, agencies and symposium/event management companies working for or on behalf of BOPA to adhere to this BOPA social media policy.
BOPA's Guide to using TwitterPlease find a handy guide to using twitter from BOPA's Digital Subcommittee. Happy tweeting!
PS Look out for the forthcoming BOPA Social Media Policy.
BOPA Bursary Scheme ProposalOne of the key roles of the British Oncology Pharmaceutical Association (BOPA) is to support its members to keep up to date with medical and pharmaceutical advances through continued education, scientific exchange and knowledge dissemination.
BOPA has achieved this by acting as an education provider, with an annual symposium, one off study days and an e-learning website. However, BOPA recognises the difficulties faced by some of its individual members in attending oncology and haematology clinical conferences and other relevant education events; due to lack of NHS study leave funding for pharmacists and increasing difficulty in accessing individual sponsorship directly from the pharmaceutical industry.
BOPA will has therefore created an educational bursary fund, which will receive contributions from BOPA funds and from the pharmaceutical industry as sponsorship or an unrestricted educational grants. BOPA will administer the bursary fund and use it to fund individual BOPA members via the bursary application process.
This document gives the background to the scheme.